Publication | Open Access
Multidrug- and Extensively Drug-Resistant <i>Mycobacterium tuberculosis</i> Beijing Clades, Ukraine, 2015
39
Citations
25
References
2020
Year
Tuberculosis PreventionGenetic EpidemiologyAntimicrobial ChemotherapyAntibiotic ResistanceDrug ResistanceMdr/xdr TbPharmacogenomicsPreventive TreatmentPublic HealthMolecular DiagnosticsAntimicrobial ResistanceBroad Drug ResistancePulmonary TuberculosisAntimicrobial Drug DiscoveryTuberculosisBacterial ResistancePharmacologyClinical MicrobiologyEpidemiologyAntimicrobial Resistance GeneAntibioticsMicrobiologyMedicineCentral Asia Outbreak
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is an emerging threat to TB control in Ukraine, a country with the third highest XDR TB burden globally. We used whole-genome sequencing of a convenience sample to identify bacterial genetic and patient-related factors associated with MDR/XDR TB in this country. MDR/XDR TB was associated with 3 distinct Mycobacterium tuberculosis complex lineage 2 (Beijing) clades, Europe/Russia W148 outbreak, Central Asia outbreak, and Ukraine outbreak, which comprised 68.9% of all MDR/XDR TB strains from southern Ukraine. MDR/XDR TB was also associated with previous treatment for TB and urban residence. The circulation of Beijing outbreak strains harboring broad drug resistance, coupled with constraints in drug supply and limited availability of phenotypic drug susceptibility testing, needs to be considered when new TB management strategies are implemented in Ukraine.
| Year | Citations | |
|---|---|---|
Page 1
Page 1